Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 Diabetes

Fediuk, DJ; Gorman, DN; Stoddard, SA; Zhang, YZ; Ogden, AG; Winton, JA; Saxena, AR

Fediuk, DJ (通讯作者),Pfizer Worldwide Res, Clin Pharmacol & Bioanalyt, Dev & Med, 445 Eastern Point Rd, Groton, CT 06340 USA.

JOURNAL OF CLINICAL PHARMACOLOGY, 2023; ():

Abstract

Danuglipron (PF-06882961) is an oral, small-molecule glucagon-like peptide-1 receptor agonist in development for the treatment of type 2 diabetes (T2D......

Full Text Link